Gray Television Commences Cash Tender Offer for Its 5.875% Senior Notes Due 2026
May 20, 2024 08:20 ET
|
Gray Television, Inc.
ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) -- Gray Television, Inc. (“Gray,” the “Company,” “we,” or “our”) (NYSE: GTN) announced today the commencement of an offer to purchase for cash (the “Tender...
Gray Announces Private Offering of Senior Secured Notes
May 20, 2024 08:19 ET
|
Gray Television, Inc.
ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) -- Gray Television, Inc. (“Gray,” “we,” “us” or “our”) (NYSE: GTN) announced today that it intends to offer up to $1 billion aggregate principal amount of...
Launch Your Merch FREE 4-Day Challenge Empowers Entrepreneurs to Build Profitable Merch Stores Online
May 20, 2024 08:10 ET
|
Launch Cart
Escondido, CA, May 20, 2024 (GLOBE NEWSWIRE) -- Launch Cart, a leader in eCommerce solutions, is proud to announce Launch Your Merch Challenge, a pioneering initiative that fosters entrepreneurship...
ONCOTELIC TO PARTICIPATE AT THE ASCO 2024 MEETING
May 20, 2024 08:10 ET
|
Oncotelic Therapeutics, Inc.
AGOURA HILLS, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its Chief Clinical Officer- Dr. Anthony Maida will be participating at the ASCO 2024...
NKGen Biotech’s SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical Trial in Alzheimer’s Disease
May 20, 2024 08:05 ET
|
NKGen Biotech, Inc.
SNK01, a cryopreserved, autologous enhanced natural killer cell therapy, delivered in highest dose to date, demonstrates preliminary clinical benefit without any drug-related adverse events. Company...
Bridger Aerospace Responds to Concerns Over Politically Motivated Attacks on its Business
May 20, 2024 08:05 ET
|
Bridger Aerospace Group Holdings, Inc.
BELGRADE, Mont., May 20, 2024 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. (“Bridger”, “the Company” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation’s largest aerial...
Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial
May 20, 2024 08:01 ET
|
Mainz BioMed NV
Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $4.0 Million
May 20, 2024 08:01 ET
|
Inhibikase Therapeutics
BOSTON and ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase...
BPMC Alert: The Law Firm of Andrews & Springer LLC Is Investigating Blueprint Medicines Corporation For Potential Securities Violations and Breaches of Fiduciary Duty
May 20, 2024 08:01 ET
|
Andrews & Springer LLC
WILMINGTON, Del., May 20, 2024 (GLOBE NEWSWIRE) -- The law firm of Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders, is investigating...
UAE Prefabricated Building and Structural Steel Market Report 2024: A US$ 1 Billion Market by 2032, Exhibiting a Growth Rate (CAGR) of 5.22% during 2023-2032
May 20, 2024 08:00 ET
|
Research and Markets
Dublin, May 20, 2024 (GLOBE NEWSWIRE) -- The "UAE Prefabricated Building and Structural Steel Market Report by Component, End Use Sector 2024-2032" report has been added to ResearchAndMarkets.com's...